Skip to content
HomeLatest newsWhat you need to know about Johnson & Johnson’s 2019 first-quarter earnings
FINAL LEDE- What You Need to Know About Johnson & Johnson's 2019 First-Quarter Earnings- Q1 Earnings 2019

What you need to know about Johnson & Johnson’s 2019 first-quarter earnings

Check out this infographic breakdown of the company’s first-quarter 2019 performance, with key highlights from its consumer, pharmaceutical and medical devices businesses.

Inset - Quarterly Earnings Ribbon

Johnson & Johnson shared financial information this morning about its first-quarter performance in 2019.

Since its founding in 1886, the company has grown to become one of the world’s largest and most broadly based healthcare companies, with approximately 135,000 employees across the globe working every day to help change the trajectory of health for humanity.

“The strength of our first-quarter results reinforces the confidence we have in our outlook for 2019,” says Joe Wolk, Executive Vice President and Chief Financial Officer, Johnson & Johnson. “Utilizing the collective and individual skills of our 135,000 global Johnson & Johnson colleagues, we continue to optimize our portfolio with discipline and make investments across the enterprise that position us to continue achieving long-term, sustainable growth and deliver significant value to patients, healthcare providers and shareholders.”

For more details about the company’s first-quarter 2019 results, and to read a message from Chairman and Chief Executive Officer Alex Gorsky, here’s an infographic packed with key stats.


1q2019-jj-earnings-infographic-final-4-16.png

Johnson & Johnson’s 2019 1st-Quarter Earnings

Read the earnings press release, which includes full financial data for the first quarter of the year.

Want to see more company earnings information? Find several years of Johnson & Johnson quarterly and full-year results here.

More from Johnson & Johnson

This scientist couldn’t save his father from lung cancer—but the targeted treatments Robert Zhao, Ph.D., has since developed have helped countless others

Learn more about Zhao, his partnership with Johnson & Johnson and antibody-drug conjugates—a new type of cancer therapy that targets and kills cancer cells without harming healthy cells.

After their husbands were diagnosed with multiple myeloma, these 3 care partners became health equity activists

Kimberly Alexander, Michelle Ware-Ivy and Marsha Calloway-Campbell learned firsthand that Black individuals develop multiple myeloma at higher rates. That’s why they joined Johnson & Johnson’s That’s My Word® health equity campaign, which builds awareness about the disparities surrounding this rare blood cancer.

How Johnson & Johnson is working to get medications to people around the world who need them most

In the just-released 2024 Access to Medicine Index, the company ranks among the top 5 improving access to medicines.